Heterocyclic compounds and uses thereof

US8969363B2 · kind B2 · utility

Assignee

• Infinity Pharmaceuticals, Inc. · US

Inventors

• Alfredo C. Castro · Woburn, US
• Catherine A. Evans · Somerville, US
• Somarajannair Janardanannair · Woburn, US
• Andre Lescarbeau · Somerville, US
• Tao Liu · Shanghai, CN
• Daniel A. Snyder · Somerville, US
• Martin Tremblay · Waltham, US
• Pingda Ren · San Diego, US
• Yi Liu · San Diego, US
• Liansheng Li · San Diego, US
• Katrina Chan · Fremont, US

Key dates

• Filing date: Jul 18, 2012
• Grant date: Mar 3, 2015
• Expiry date: Jul 18, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D513/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.